Wholehealth Products, Inc. (GWPC) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
DELISTED
What happened to Wholehealth Products, Inc. (GWPC) stock?
Wholehealth Products, Inc. (GWPC) no longer trades on public markets. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Wholehealth Products, Inc. (GWPC). Wholehealth Products, Inc. develops, manufactures, and markets in vitro diagnostic tests for over-the-counter (OTC) and point-of-care use in the United States. Sector: Healthcare.
Last analyzed: Mar 16, 2026Analyst Coverage for GWPC: GWPC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates GWPC against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
GWPC: this read rests on a single discipline (Legends Council) — the other council disciplines have no scored data yet.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Wholehealth Products, Inc. (GWPC) Healthcare & Pipeline Overview
Wholehealth Products, Inc. focuses on developing, manufacturing, and marketing in vitro diagnostic tests for OTC and point-of-care markets in the U.S. The company provides diagnostic test kits for consumer and professional use, operating in a competitive healthcare landscape with a small employee base and OTC market focus.
What Is the Investment Thesis for GWPC?
Wholehealth Products, Inc. operates in the niche market of OTC and point-of-care in vitro diagnostic tests. The company's small size, with only four employees, presents both opportunities and challenges. Key value drivers include expanding its product line of diagnostic test kits and increasing market penetration in the U.S. healthcare sector. Growth catalysts involve securing partnerships with major retailers for OTC sales and expanding distribution networks to reach more healthcare facilities. However, potential risks include intense competition from larger players in the diagnostics market and the need for continuous innovation to maintain a competitive edge. The company's beta of -3084.77 indicates high volatility relative to the market.
Based on FMP financials and quantitative analysis
GWPC Key Highlights
Focus on in vitro diagnostic tests for OTC and point-of-care markets.
- Serves both consumer and healthcare professional segments.
- Operates primarily within the United States.
- Small employee base of 4 individuals.
- Formerly known as Gulf Western Petroleum Corporation, indicating a significant business transformation.
Who Are GWPC's Competitors?
GWPC is benchmarked below against 3 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| QTEX Inspira Technologies Oxy B.H.N. Ltd. | $0.82 | -0.87% | $35.7M | 435-pillar |
| SI SHOULDER INNOVATIONS, INC. | $19.27 | +0.84% | $400M | 365-pillar |
| EBOSY EBOS Group Limited | $26.00 | -0.38% | $1.33B | 429-signal |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are GWPC's Key Strengths?
Focus on niche market of OTC and point-of-care diagnostic tests.
- Established presence in the U.S. market.
- Proprietary diagnostic test kit formulations.
- Serves both consumer and professional healthcare segments.
What Are GWPC's Weaknesses?
Small employee base limits operational capacity.
- Limited financial resources compared to larger competitors.
- Dependence on a limited product line.
- OTC Other tier listing indicates higher risk and lower liquidity.
What Could Drive GWPC Stock Higher?
Potential partnerships with major retailers to expand OTC product distribution.
- Development and launch of new diagnostic test kits for common ailments.
- Increasing demand for point-of-care diagnostic solutions in medical clinics and hospitals.
What Are the Key Risks for GWPC?
Intense competition from larger diagnostic companies with greater resources.
- Evolving regulatory landscape for diagnostic tests may require significant compliance costs.
- Technological obsolescence of existing products due to rapid advancements in diagnostics.
- Limited financial resources may hinder growth and expansion efforts.
- OTC Other tier listing indicates higher risk and lower liquidity.
What Are the Growth Opportunities for GWPC?
- Expanding OTC Product Line: Wholehealth Products, Inc. can capitalize on the growing demand for at-home diagnostic tests by expanding its OTC product line. The global OTC drugs market is projected to reach $220 billion by 2027. Introducing new diagnostic kits for common ailments and health monitoring can drive revenue growth and increase market share. Timeline: Launching 2-3 new OTC products per year.
- Strategic Partnerships with Retailers: Forming strategic partnerships with major retailers and pharmacies can significantly enhance the distribution and accessibility of Wholehealth Products' OTC diagnostic tests. Securing shelf space in national chains can drive sales volume and brand recognition. The retail pharmacy market is a key channel for reaching consumers seeking convenient healthcare solutions. Timeline: Establishing partnerships with 1-2 major retailers within the next 2 years.
- Penetrating the Point-of-Care Market: Expanding its presence in the point-of-care market by targeting medical clinics, physician offices, and hospitals can drive revenue growth. Offering diagnostic solutions that improve efficiency and patient outcomes can attract healthcare providers. The point-of-care diagnostics market is expected to grow as healthcare systems prioritize rapid and accurate testing. Timeline: Increasing sales to healthcare providers by 15% annually.
- Geographic Expansion within the U.S.: While currently focused on the U.S. market, Wholehealth Products, Inc. can explore opportunities for geographic expansion within the country. Targeting regions with high population density and unmet healthcare needs can drive revenue growth. Conducting market research to identify underserved areas and tailoring product offerings to local needs can be effective strategies. Timeline: Expanding sales operations to 2-3 new states within the next 3 years.
- Developing Innovative Diagnostic Technologies: Investing in research and development to develop innovative diagnostic technologies can provide a competitive edge and attract new customers. Focusing on areas such as rapid testing, personalized medicine, and digital health solutions can position Wholehealth Products, Inc. as a leader in the diagnostics market. The global diagnostics market is driven by technological advancements and the need for more accurate and efficient testing methods. Timeline: Launching 1-2 innovative diagnostic products within the next 5 years.
What Are GWPC's Competitive Advantages?
- Specialized focus on in vitro diagnostic tests for OTC and point-of-care markets.
- Established presence in the U.S. diagnostic testing market.
- Proprietary diagnostic test kit formulations and manufacturing processes.
What Does GWPC Do?
Incorporated in 2006 and based in Las Vegas, Nevada, Wholehealth Products, Inc. has evolved from Gulf Western Petroleum Corporation to a healthcare company specializing in in vitro diagnostic tests. This transformation, completed in July 2012, marked a strategic shift towards the development, manufacturing, and marketing of diagnostic solutions. The company targets both the over-the-counter (OTC) market, providing consumers with accessible diagnostic tools, and the point-of-care sector, serving healthcare professionals in medical clinics, physician offices, and hospitals. Their product range includes a variety of diagnostic test kits designed for ease of use and rapid results. Wholehealth Products operates primarily within the United States, focusing on delivering diagnostic solutions directly to consumers and healthcare providers. With a small team of four employees, the company navigates a competitive landscape, emphasizing innovation and market reach within its niche.
What Products and Services Does GWPC Offer?
- Develops in vitro diagnostic tests.
- Manufactures diagnostic test kits.
- Markets diagnostic tests for over-the-counter (OTC) use.
- Markets diagnostic tests for point-of-care use.
- Provides diagnostic solutions for consumers.
- Provides diagnostic solutions for healthcare professionals.
How Does GWPC Make Money?
- Develops and manufactures in vitro diagnostic tests.
- Sells diagnostic test kits directly to consumers through OTC channels.
- Sells diagnostic test kits to healthcare professionals for point-of-care use.
What Industry Does GWPC Operate In?
Wholehealth Products, Inc. operates within the medical specialties industry, a segment of the broader healthcare sector. This industry is characterized by rapid technological advancements, evolving regulatory landscapes, and increasing demand for point-of-care diagnostics. The market for in vitro diagnostic tests is projected to grow, driven by factors such as the aging population, rising prevalence of chronic diseases, and the shift towards personalized medicine. Competition includes established players like ALEAF, DGCRF, HHPHF, HRTT, and HTPRF, as well as smaller, specialized firms. Success in this industry requires continuous innovation, strategic partnerships, and effective market penetration.
Who Are GWPC's Key Customers?
- Individual consumers seeking over-the-counter diagnostic tests.
- Medical clinics using point-of-care diagnostic tests.
- Physician offices utilizing diagnostic tests for patient care.
- Hospitals employing diagnostic tests for various medical purposes.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price 5 days old
- ● No filing on record
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 4 snapshots
| 2026-08-23 | 46 |
| 2026-08-24 | 46 |
| 2026-08-25 | 46 |
| 2026-08-26 | 46 |
What changed?
The score has stayed at 46.
Over the same 3 days the stock moved +0.0%.
Company Profile
Wholehealth Products, Inc. operates in the Medical - Specialties industry within the Healthcare sector. The company is led by CEO Charles A. Strongo BA, MBA. GWPC has traded publicly since 2005.
GWPC Financials
Bull Case vs Bear Case
Bull Case
- Focus on niche market of OTC and point-of-care diagnostic tests.
- Established presence in the U.S. market.
- Proprietary diagnostic test kit formulations.
- Serves both consumer and professional healthcare segments.
Bear Case
- Small employee base limits operational capacity.
- Limited financial resources compared to larger competitors.
- Dependence on a limited product line.
- OTC Other tier listing indicates higher risk and lower liquidity.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
GWPC Latest News
No recent news available for GWPC.
Leadership: Charles A. Strongo BA, MBA
CEO
Charles A. Strongo serves as the CEO of Wholehealth Products, Inc. He holds a Bachelor of Arts (BA) and a Master of Business Administration (MBA). His background likely includes experience in business management, strategic planning, and financial oversight. With responsibility for managing a small team of four employees, Strongo's role encompasses a wide range of functions, from product development and marketing to sales and operations. His leadership is crucial for driving the company's growth and navigating the competitive healthcare market.
Track Record: Given the limited information available, it is difficult to assess Charles A. Strongo's specific track record at Wholehealth Products, Inc. However, as CEO, he has overseen the company's operations and strategic direction. Key achievements may include expanding the product line, securing partnerships, and increasing market share. His decisions regarding product development, marketing strategies, and financial management have likely influenced the company's performance and growth trajectory.
GWPC OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Wholehealth Products, Inc. may not meet the minimum financial or disclosure requirements of the higher tiers like OTCQX or OTCQB. Companies in this tier often have limited regulatory oversight and may not be required to file regular financial reports with the SEC. This lack of transparency can make it more difficult for investors to assess the company's financial health and performance compared to companies listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries a higher degree of risk due to the limited information available and the potential for fraud or manipulation.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency.
- Low trading volume and liquidity.
- Potential for price manipulation and fraud.
- Higher risk of delisting or going out of business.
- Limited regulatory oversight and investor protection.
- Verify the company's legal status and registration.
- Obtain and review any available financial statements.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Understand the risks associated with investing in OTC Other stocks.
- Consult with a qualified financial advisor.
- Check for any regulatory actions or legal disputes involving the company.
- Company has been in operation since 2006.
- Focus on developing and manufacturing diagnostic tests.
- Serves both consumer and healthcare professional markets.
- Company changed its name to Wholehealth Products, Inc. in July 2012.
Wholehealth Products, Inc. Healthcare Stock: Key Questions Answered
What happened to Wholehealth Products, Inc. (GWPC) stock?
Wholehealth Products, Inc. (GWPC) no longer trades on public markets. The figures below are historical and are not a current quote.
Can I still buy GWPC shares?
No. GWPC stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for GWPC elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before GWPC stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Wholehealth Products, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Wholehealth Products, Inc. do?
Wholehealth Products, Inc. is a healthcare company that develops, manufactures, and markets in vitro diagnostic tests for over-the-counter (OTC) and point-of-care use in the United States.
What do analysts say about GWPC stock?
Given the company's OTC Other tier listing and limited financial disclosure, traditional analyst coverage may be scarce. Investors should conduct their own thorough due diligence and consider the risks associated with investing in thinly traded, less transparent companies. Key valuation metrics may be difficult to obtain due to the lack of readily available financial data.
What are the main risks for GWPC?
The main risks for Wholehealth Products, Inc. include intense competition from larger diagnostic companies, the evolving regulatory landscape for diagnostic tests, and the potential for technological obsolescence of existing products.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available due to OTC Other tier listing and unknown disclosure status.